BioMarin Pharmaceutical Inc.

2024-08-22

Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Biopharmaceuticals - BioMarin Pharmaceutical Inc.. Researches and develops therapies for debilitating, fatal, chronic genetic disorders causing enzyme deficiency of carbohydrate metabolism, such as phenylketonuria.

Researches and develops therapies for debilitating, fatal, chronic genetic disorders causing enzyme deficiency of carbohydrate metabolism, such as phenylketonuria. Headquarters in Novato, California. (Nasdaq: BMRN).